Radiation Impact on Thromboembolic Events

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-06-14

Study Completion Date

2019-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study is to determine the frequency and to identify main risk factors for venous thromboembolism of venous thromboembolic complications in a population of cancer patients treated with a curative intent by ionizing radiation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Coagulation System In STereotactic Radiotherapy Of NSCLC

NCT03893461

Thromboembolism Lung Cancer NSCLC +1 more

UNKNOWN

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

NCT02439008

Carcinoma, Hepatocellular Colorectal Neoplasms Melanoma +1 more

TERMINATED NA

Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

NCT02457962

Solid Tumors Hematologic Malignancies

ACTIVE_NOT_RECRUITING

A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas

NCT02994264

Sarcoma,Soft Tissue

COMPLETED

Evaluation of Technological Innovation in Radiotherapy

NCT03378856

Cancer Radiotherapy Side Effect

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malignant Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cancer treated by radiotherapy

Patient with a solid cancer (all locations) treated with radiation therapy and/or brachytherapy as curative intent

Biomarkers assays

Intervention Type BIOLOGICAL

D-Dimer assays, C-reactive protein, blood platelets assays

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biomarkers assays

D-Dimer assays, C-reactive protein, blood platelets assays

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient with a solid cancer (all locations) treated with radiation therapy and / or brachytherapy as curative intent
* to be 18

Exclusion Criteria

* Patient with metastatic cancer,
* Patients whose follow-up at 6 months is not possible
* Patient receiving an anti-coagulative medication (curative doses)
* Pregnant or breastfeeding women,
* Person under protection of justice or unable to give consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No